Cidara Therapeutics, Inc.

The current price of CDTX is 0.6810 USD — it has decreased by 5.68% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cidara Therapeutics, Inc. stocks are traded under the ticker CDTX.

Cidara Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

CDTX stock is 8.82% volatile and has beta coefficient of 0.68. Check out the list of the most volatile stocks — is Cidara Therapeutics, Inc. there?

One year price forecast for Cidara Therapeutics, Inc. has a max estimate of 6.0000 USD and a min estimate of 6.0000 USD.

CDTX earnings for the last quarter are −0.09 USD per share, whereas the estimation was −0.15 USD resulting in a 40.00% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about Cidara Therapeutics, Inc. earnings.

Cidara Therapeutics, Inc. revenue for the last quarter amounts to ‪12.72 M‬ USD despite the estimated figure of ‪8.14 M‬ USD. In the next quarter revenue is expected to reach ‪11.53 M‬ USD.

Yes, you can track Cidara Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

CDTX net income for the last quarter is ‪−8.17 M‬ USD, while the quarter before that showed ‪−12.36 M‬ USD of net income which accounts for 33.87% change. Track more Cidara Therapeutics, Inc. financial stats to get the full picture.

No, CDTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, CDTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cidara Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

CDTX reached its all-time high on Apr 15, 2015 with the price of 19.1300 USD, and its all-time low was 0.4000 USD and was reached on Jun 6, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 20, 2024, the company has 73.00 employees. See our rating of the largest employees — is Cidara Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cidara Therapeutics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cidara Therapeutics, Inc. stock shows the sell signal. See more of Cidara Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Cidara Therapeutics, Inc. future price: according to them, CDTX price has a max estimate of 6.00 USD and a min estimate of 6.00 USD. Read a more detailed Cidara Therapeutics, Inc. forecast: see what analysts think of Cidara Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cidara Therapeutics, Inc. EBITDA is ‪−30.65 M‬ USD, and current EBITDA margin is −46.00%. See more stats in Cidara Therapeutics, Inc. financial statements.